Using the Oxford Cognitive Screen Test to identify cognitive issues in stroke patients
Clinical Utility of Oxford Cognitive Screen Test to Screen Cognitive Impairment in Post Stroke Patients
This study is testing whether a Korean version of a cognitive test can help identify thinking problems in people who have had a stroke.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 100 (estimated) |
| Ages | 20 Years and up |
| Sex | All |
| Sponsor | Bundang CHA Hospital Academic / other |
| Locations | 1 site (Seongnam-si, Gyeonggi-do) |
| Trial ID | NCT06348901 on ClinicalTrials.gov |
What this trial studies
This observational study aims to evaluate the clinical utility of the Korean version of the Oxford Cognitive Screen (K-OCS) in detecting cognitive impairment in post-stroke patients. It will assess the reliability, validity, sensitivity, specificity, and diagnostic accuracy of the K-OCS compared to existing assessment tools. The study will involve stroke patients who meet specific inclusion criteria and will analyze participation rates in cognitive assessments. The goal is to determine the effectiveness of K-OCS in identifying cognitive deficits following a stroke.
Who should consider this trial
Good fit: Ideal candidates for this study are adults over 20 years of age who have experienced a stroke more than 72 hours prior and have been diagnosed by medical specialists.
Not a fit: Patients who do not meet the inclusion criteria or those who are unable to participate in cognitive assessments may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide a reliable tool for early detection of cognitive impairment in stroke patients, leading to better management and rehabilitation strategies.
How similar studies have performed: Other studies have shown success in using cognitive screening tools for post-stroke patients, indicating that this approach is supported by existing research.
Eligibility criteria
Show full inclusion / exclusion criteria
For stroke patients 1. Inclusion Criteria: * Adults over 20 years of age * More than 72 hours elapsed since the onset of stroke symptoms. * After hearing a detailed explanation of this study and fully understanding it, the subject or legal representative voluntarily decides to participate and agrees in writing to observe the precautions * Involved individuals diagnosed with stroke by neurology and rehabilitation medicine specialists based on data acquired from 3T GE Signa System (General Electric, Milwaukee, WI), brain magnetic resonance imaging (MRI), and computed tomography (CT). 2. Exclusion Criteria: * Who cannot meet the inclusion criteria For healthy voluteers 1. Inclusion Criteria: * Over 20 years of age * A person who is performing an independent daily life * A person who voluntarily decides to participate and agrees in writing to abide by the precautions after hearing a detailed explanation of this study and fully understanding it 2. Exclusion Criteria: * Who cannot meet the inclusion criteria
Where this trial is running
Seongnam-si, Gyeonggi-do
- Department of Rehabilitation Medicine, CHA Bundang Medical Center — Seongnam-si, Gyeonggi-do, Korea, Republic of (Recruiting)
Study contacts
- Study coordinator: Eunyoung Cho
- Email: a220242@chamc.co.kr
- Phone: +82-10-2753-0285
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.